Miralbell Raymond, Ozsoy Orhan, Pugliesi Angela, Carballo Natalia, Arnalte Raquel, Escudé Lluís, Jargy Clara, Nouet Philippe, Rouzaud Michel
Division de Radio-oncologie, Hôpitaux Universitaires de Genève-CH, 1211Geneva 14, Switzerland.
Radiother Oncol. 2003 Feb;66(2):197-202. doi: 10.1016/s0167-8140(02)00368-7.
To assess the influence of patient repositioning and organ motion on dose distribution within the prostate and the seminal vesicles (clinical target volume, (CTV)).
Nine patients were simulated and treated in the supine position, with an empty bladder, and without immobilization devices. While on treatment, patients underwent weekly pelvic computed tomography (CT) scans under conditions identical to those at simulation. Patients were aligned using lasers on anterior and lateral skin tattoos, onto which lead markers were placed. After each CT scan (n=53) the CTV was redefined by contouring, and a new isocenter was obtained. A six-field technique was used. The field margins around the CTV were 20 mm in the cranio-caudal axis, and 13 mm in the other axes, except in the lateral fields where a 10 mm posterior margin was used. Dose-volume histograms (DVHs) for each organ were compared with those determined at simulation, using the notion of the proportional change in the area under the CTV-DVH curve resulting from a change in treatment plan (cDVH).
The reproducibility of the dose distribution was good for the prostate (%cDVH, mean+/-SD: -0.97+/-2.11%) and less than optimal for the seminal vesicles (%cDVH, mean+/-SD: -4.66+/-10.45%). When correlating prostate %cDVH variations with displacements of the isocenter in the Y axis (antero-posterior) the %cDVH exceeded (-)5% in only two dosimetries, both with an isocenter shift of >10 mm. For the seminal vesicles, however, ten out of 53 dosimetries showed a %cDVH exceeding (-) 5%. In nine of these ten dose distribution studies the posterior shift of the isocenter exceeded 8 mm.
Precise targeting of prostate radiotherapy is primarily dependent on careful daily set-up and on random changes in rectal geometry. Margins no less than 10 mm around the prostate and at least 15 mm around the seminal vesicles are probably necessary to insure adequate target coverage with a six-field technique.
评估患者重新定位和器官运动对前列腺及精囊(临床靶区,CTV)内剂量分布的影响。
对9例患者进行模拟并在仰卧位、膀胱排空且无固定装置的情况下进行治疗。治疗期间,患者每周在与模拟时相同的条件下接受盆腔计算机断层扫描(CT)。利用前后和外侧皮肤标记上的激光对患者进行对齐,并在标记上放置铅标记物。每次CT扫描(n = 53)后,通过轮廓勾画重新定义CTV,并获得新的等中心。采用六野技术。CTV在头脚轴上的野边缘为20 mm,在其他轴上为13 mm,但在外侧野使用10 mm的后缘。使用治疗计划变化导致的CTV -剂量体积直方图(DVH)曲线下面积的比例变化概念(cDVH),将每个器官的剂量体积直方图与模拟时确定的进行比较。
前列腺剂量分布的可重复性良好(%cDVH,平均值±标准差:-0.97±2.11%),精囊的可重复性则不太理想(%cDVH,平均值±标准差:-4.66±10.45%)。当将前列腺%cDVH变化与等中心在Y轴(前后)的位移相关联时,仅在两次剂量测定中%cDVH超过(-)5%,且两次等中心移位均>10 mm。然而,对于精囊,53次剂量测定中有10次显示%cDVH超过(-)5%。在这10项剂量分布研究中的9项中,等中心的后移超过8 mm。
前列腺放疗的精确靶向主要取决于每日仔细摆位以及直肠几何形状的随机变化。采用六野技术时,前列腺周围至少10 mm、精囊周围至少15 mm的边缘可能是确保足够靶区覆盖所必需的。